High BMI Tied to Better Overall Survival in Immune Checkpoint Inhibitor-Treated Metastatic RCC

NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma (mRCC) treated with PD-1/PD-L1-based immune checkpoint inhibitors (ICIs),

Read more